What is the starting dose of lorazepam (Ativan) for adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lorazepam Starting Dose for Adults

For adults with anxiety, the standard starting dose of lorazepam is 2-3 mg/day given in divided doses (typically twice or three times daily), with the largest dose taken at bedtime. 1

Standard Dosing by Indication

Anxiety Disorders

  • Initial dose: 2-3 mg/day in divided doses (twice or three times daily) 1
  • The usual therapeutic range is 2-6 mg/day, though daily dosage may vary from 1-10 mg/day depending on response 1
  • The largest dose should be taken before bedtime 1

Insomnia Due to Anxiety

  • Single daily dose of 2-4 mg at bedtime 1
  • This applies to insomnia related to anxiety or transient situational stress 1

Acute Agitation (Emergency/Psychiatric Settings)

  • 1 mg PRN (orally if cooperative; parenteral if not) 2
  • Can be administered as frequently as every hour if needed, though 4-8 hour intervals are often sufficient 2
  • Maximum single dose for acute agitation: up to 2 mg IV/subcutaneous 2

Special Population Adjustments

Elderly or Debilitated Patients

  • Reduced starting dose: 1-2 mg/day in divided doses 1
  • Lower doses (0.25-0.5 mg) may be appropriate if the patient is frail or has respiratory conditions like COPD due to risk of excessive sedation 2
  • Elderly patients are especially sensitive to benzodiazepine effects 3

Parenteral Administration (Anesthesia/Procedural Sedation)

  • 0.04-0.06 mg/kg IV or IM for preanesthetic medication 4
  • This dosing has been shown most effective for antianxiety and antirecall effects 4

Important Dosing Principles

Titration Strategy

  • Increase dosage gradually when higher doses are needed to avoid adverse effects 1
  • When increasing, the evening dose should be raised before daytime doses 1
  • Dose adjustments should be made based on patient response and tolerability 1

Administration with Oral Concentrate

  • Must be mixed with liquid or semi-solid food (water, juice, applesauce, pudding) 1
  • Use only the calibrated dropper provided 1
  • Consume entire mixture immediately; do not store for future use 1

Critical Safety Considerations

Monitoring Requirements

  • Monitor for excessive sedation, especially when combined with other CNS depressants 2
  • Watch for paradoxical agitation, which occurs in approximately 10% of patients treated with benzodiazepines 2
  • Increased fall risk, particularly in elderly patients 2

Discontinuation

  • Use gradual taper to reduce risk of withdrawal reactions 1
  • If withdrawal symptoms develop, pause the taper or increase to previous dose level, then decrease more slowly 1
  • Abrupt discontinuation can cause marked rebound insomnia and increased anxiety 5

Duration Considerations

  • Avoid regular, long-term use due to risks of tolerance, addiction, and cognitive impairment 2
  • The drug's duration of action (elimination half-life 8-25 hours) makes it unsuitable for outpatient procedures or hospital stays less than 72 hours 4, 6

Common Pitfalls to Avoid

  • Underdosing in status epilepticus: While not the primary indication here, it's worth noting that doses less than 4 mg in SE are associated with progression to refractory status 7
  • Inadequate dose titration: Starting too high in elderly/debilitated patients increases adverse effects 1
  • Abrupt discontinuation: Always taper to prevent withdrawal phenomena 1, 5
  • Ignoring drug interactions: Lorazepam potentiates other CNS depressants including alcohol, opioids, and antipsychotics 2

References

Guideline

Management of Acute Agitation in Bipolar and Schizophrenia Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical pharmacology of lorazepam.

Contemporary anesthesia practice, 1983

Research

Clinical pharmacokinetics of oxazepam and lorazepam.

Clinical pharmacokinetics, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.